We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Research Seems to Be Gaining Upper Hand on What's Been Called Non-A, Non-B Hepatitis

Charles Marwick; Andrew Skolnick
JAMA. 1990;263(1):14-17. doi:10.1001/jama.1990.03440010012004.
Text Size: A A A
Published online


TWO REPORTS on hepatitis virus type C (HCV) in this issue of JAMA, as well as recent articles elsewhere (N Engl J Med. 1989;321:1538-1539, 1494-1500, and 1501-1510), provide strong evidence that the long, frustrating search for the cause of most—if not all— of what has been called non-A, non-B (NANB) hepatitis may be over and that a better blood-screening assay to prevent tranfusion-associated NANB hepatitis may soon be available.

This so-called NANB hepatitis has accounted for a substantial proportion of acute and chronic liver disease in the United States. According to Miriam J. Alter, PhD, chief of hepatitis surveillance, Centers for Disease Control (CDC), Atlanta, Ga, approximately 150 000 NANB hepatitis infections occur each year in this country, half of which produce biochemical evidence of chronic liver disease, with approximately 15 000 leading to chronic active hepatitis or cirrhosis.

In addition, the virus may be causally associated with hepatocellular carcinoma.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.